TEGLUTIK susp 50 mg/10ml buvable fl 300 ml

7680664340013 CH-66434 N07XX02 01.99.0.

Active substances:

TEGLUTIK susp 50 mg/10ml buvable fl 300 ml
TEGLUTIK susp 50 mg/10ml buvable fl 300 ml
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
6643401
CPT
-
Packaging group
300
Unit
ml
Composition
riluzolum 50 mg, sorbitolum liquidum non cristallisabile 5.7143 g, aluminii magnesii silicas, xanthani gummi, saccharinum natricum, simeticonum, polysorbatum 65, methylcellulosum, silica colloidalis hydrica, macrogoli stearas, glyceroli mono/dimyristas/palmitas/stearas, E 200, E 210 max. 0.3 µg, acidum sulfuricum, natrii laurilsulfas, macrogoli aether cetostearylicus, aqua purificata ad suspensionem pro 10 ml corresp. natrium 1.14 mg.

Articles (1)

Teglutik 50mg/10ml, suspension buvable
suspension
300
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
10/08/2022
Patient information leaflet
Français
10/08/2022
Patient information leaflet
Italien
10/08/2022
Professional SmPC
Allemand
09/08/2022
Professional SmPC
Français
09/08/2022
Professional SmPC
Italien
09/08/2022

Detailed composition

Substance Quantity Type Category
riluzolum
50.0 MG Substance Wirkstoff (Principe actif)
sorbitolum liquidum non cristallisabile
5.7143 G Substance HBESI
aluminii magnesii silicas
- Substance HNIDK
xanthani gummi
- Substance HNIDK
saccharinum natricum
- Substance AIMDK
simeticonum
- Substance HNIDK
polysorbatum 65
- Substance HNIDK
methylcellulosum
- Substance HNIDK
silica colloidalis hydrica
- Substance HNIDK
macrogoli stearas
- Substance HNIDK
glyceroli mono/dimyristas/palmitas/stearas
- Substance HNIDK
E 200
- Substance Konservierungsstoff (Conservateur)
E 210
- Substance HBESI
acidum sulfuricum
- Substance HNIDK
natrii laurilsulfas
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
macrogoli aether cetostearylicus
- Substance HNIDK
aqua purificata
- Substance HNIDK
natrium
1.14 MG Substance HBESI

Reimbursement information

Public price
CHF 127.35
Specialties list
Yes
Generic
No
SL addition date: 01/10/2018

Authorization holder

EFFIK SA

1260 Nyon

Authorization information

Swissmedic authorization number
66434
Drug name
Teglutik, suspension buvable
Galenic form
SUOR
ATC Code
N07XX02
Authorization status
Z
Dispensation category
B
First authorization
26/04/2018
Authorization expiration date
31/12/9999
IT number
01.99.0.
Domain
Human medicine

Packaging details

Description (FR)
TEGLUTIK susp 50 mg/10ml buvable fl 300 ml
Description (DE)
TEGLUTIK Susp 50 mg/10ml zum Einnehmen Fl 300 ml
Market launch
26/04/2018
Narcotic (BTM)
No
Buy us a coffee Explore the data